Global Aminocaproic Acid 麻豆原创 Growth 2025-2031

Publication ID:

LPI08251684

Publication Date:

August 4, 2025

Pages:

121

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Aminocaproic Acid market size is predicted to grow from US$ 129 million in 2025 to US$ 158 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Aminocaproic acid, also known as 蔚-aminocaproic acid, is a synthetic antifibrinolytic agent structurally similar to lysine. It works by inhibiting the conversion of plasminogen to plasmin, thereby preventing the premature breakdown of blood clots. This makes it effective in managing abnormal bleeding associated with surgery, trauma, or bleeding disorders. Available in both oral and intravenous forms, aminocaproic acid is widely used in surgical, urological, and obstetric settings, especially for perioperative hemostasis and supportive treatment of hemorrhagic conditions.
Aminocaproic acid remains a staple antifibrinolytic drug with a long-standing role in clinical practice across many countries. It is widely used in surgical procedures, trauma care, urological bleeding, and obstetric interventions. The market consists of both branded and numerous generic versions, with generic competition dominating. Available in oral solutions, tablets, and injectables, the drug is adaptable to varied clinical settings. Its mature therapeutic profile, affordability, and favorable safety record have secured its inclusion in national formularies and reimbursement schemes across major markets like North America, Europe, India, and China, ensuring steady demand.The market outlook for aminocaproic acid is expected to remain stable, with modest growth fueled by global population aging and rising surgical volumes. As healthcare systems place greater emphasis on perioperative management and transfusion reduction, the role of antifibrinolytic agents is set to expand. In emerging economies, improvements in healthcare access and infrastructure will further consolidate the drug's position as a fundamental hemostatic agent. Meanwhile, select manufacturers are investing in higher-value formulations such as sterile injectables, high-purity variants, and combination products to differentiate in a competitive environment and enhance regulatory positioning.Key growth drivers include the consistent rise in surgical and trauma-related procedures, increasing adherence to antifibrinolytic therapy guidelines, heightened awareness of perioperative bleeding management, and strong support for cost-effective generics in public health systems. However, challenges persist: concerns over potential thrombotic risks have led to cautious use in some countries, and the emergence of newer, more targeted antifibrinolytic agents may gradually erode demand. Additionally, due to its simple structure and mature manufacturing process, the low entry barrier has resulted in intense competition and downward pricing pressure, posing margin and sustainability challenges for smaller producers.
The 鈥淎minocaproic Acid Industry Forecast鈥� looks at past sales and reviews total world Aminocaproic Acid sales in 2024, providing a comprehensive analysis by region and market sector of projected Aminocaproic Acid sales for 2025 through 2031. With Aminocaproic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminocaproic Acid industry.
This Insight Report provides a comprehensive analysis of the global Aminocaproic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminocaproic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Aminocaproic Acid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminocaproic Acid and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminocaproic Acid.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminocaproic Acid market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Injection
Tablet
Oral Solutions
Other
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Daiichi Sankyo
Civica
Yangzhou Zhongbao Pharmaceutical
Chengdu Brilliant Pharmaceutical
Hunan Er-Kang Pharmaceutical
Changzhou Lanling Pharmaceutical
Baiao Pharmaceutical
Guangdong Wonterfull ITD Pharmaceutical
Jiangsu Yuexing Pharmaceutical
Southwest Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aminocaproic Acid market?
What factors are driving Aminocaproic Acid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminocaproic Acid market opportunities vary by end market size?
How does Aminocaproic Acid break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Aminocaproic Acid Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aminocaproic Acid by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aminocaproic Acid by Country/Region, 2020, 2024 & 2031
2.2 Aminocaproic Acid Segment by Type
2.2.1 Injection
2.2.2 Tablet
2.2.3 Oral Solutions
2.2.4 Other
2.3 Aminocaproic Acid Sales by Type
2.3.1 Global Aminocaproic Acid Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Aminocaproic Acid Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Aminocaproic Acid Sale Price by Type (2020-2025)
2.4 Aminocaproic Acid Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Aminocaproic Acid Sales by Application
2.5.1 Global Aminocaproic Acid Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Aminocaproic Acid Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Aminocaproic Acid Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Aminocaproic Acid Breakdown Data by Company
3.1.1 Global Aminocaproic Acid Annual Sales by Company (2020-2025)
3.1.2 Global Aminocaproic Acid Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Aminocaproic Acid Annual Revenue by Company (2020-2025)
3.2.1 Global Aminocaproic Acid Revenue by Company (2020-2025)
3.2.2 Global Aminocaproic Acid Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Aminocaproic Acid Sale Price by Company
3.4 Key Manufacturers Aminocaproic Acid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminocaproic Acid Product Location Distribution
3.4.2 Players Aminocaproic Acid Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Aminocaproic Acid by Geographic Region
4.1 World Historic Aminocaproic Acid 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Aminocaproic Acid Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aminocaproic Acid Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aminocaproic Acid 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Aminocaproic Acid Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aminocaproic Acid Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aminocaproic Acid Sales Growth
4.4 APAC Aminocaproic Acid Sales Growth
4.5 Europe Aminocaproic Acid Sales Growth
4.6 Middle East & Africa Aminocaproic Acid Sales Growth
5 Americas
5.1 Americas Aminocaproic Acid Sales by Country
5.1.1 Americas Aminocaproic Acid Sales by Country (2020-2025)
5.1.2 Americas Aminocaproic Acid Revenue by Country (2020-2025)
5.2 Americas Aminocaproic Acid Sales by Type (2020-2025)
5.3 Americas Aminocaproic Acid Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aminocaproic Acid Sales by Region
6.1.1 APAC Aminocaproic Acid Sales by Region (2020-2025)
6.1.2 APAC Aminocaproic Acid Revenue by Region (2020-2025)
6.2 APAC Aminocaproic Acid Sales by Type (2020-2025)
6.3 APAC Aminocaproic Acid Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aminocaproic Acid by Country
7.1.1 Europe Aminocaproic Acid Sales by Country (2020-2025)
7.1.2 Europe Aminocaproic Acid Revenue by Country (2020-2025)
7.2 Europe Aminocaproic Acid Sales by Type (2020-2025)
7.3 Europe Aminocaproic Acid Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aminocaproic Acid by Country
8.1.1 Middle East & Africa Aminocaproic Acid Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aminocaproic Acid Revenue by Country (2020-2025)
8.2 Middle East & Africa Aminocaproic Acid Sales by Type (2020-2025)
8.3 Middle East & Africa Aminocaproic Acid Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aminocaproic Acid
10.3 Manufacturing Process Analysis of Aminocaproic Acid
10.4 Industry Chain Structure of Aminocaproic Acid
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aminocaproic Acid Distributors
11.3 Aminocaproic Acid Customer
12 World Forecast Review for Aminocaproic Acid by Geographic Region
12.1 Global Aminocaproic Acid 麻豆原创 Size Forecast by Region
12.1.1 Global Aminocaproic Acid Forecast by Region (2026-2031)
12.1.2 Global Aminocaproic Acid Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aminocaproic Acid Forecast by Type (2026-2031)
12.7 Global Aminocaproic Acid Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Aminocaproic Acid Product Portfolios and Specifications
13.1.3 Pfizer Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Daiichi Sankyo
13.2.1 Daiichi Sankyo Company Information
13.2.2 Daiichi Sankyo Aminocaproic Acid Product Portfolios and Specifications
13.2.3 Daiichi Sankyo Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Daiichi Sankyo Main Business Overview
13.2.5 Daiichi Sankyo Latest Developments
13.3 Civica
13.3.1 Civica Company Information
13.3.2 Civica Aminocaproic Acid Product Portfolios and Specifications
13.3.3 Civica Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Civica Main Business Overview
13.3.5 Civica Latest Developments
13.4 Yangzhou Zhongbao Pharmaceutical
13.4.1 Yangzhou Zhongbao Pharmaceutical Company Information
13.4.2 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.4.3 Yangzhou Zhongbao Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Yangzhou Zhongbao Pharmaceutical Main Business Overview
13.4.5 Yangzhou Zhongbao Pharmaceutical Latest Developments
13.5 Chengdu Brilliant Pharmaceutical
13.5.1 Chengdu Brilliant Pharmaceutical Company Information
13.5.2 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.5.3 Chengdu Brilliant Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chengdu Brilliant Pharmaceutical Main Business Overview
13.5.5 Chengdu Brilliant Pharmaceutical Latest Developments
13.6 Hunan Er-Kang Pharmaceutical
13.6.1 Hunan Er-Kang Pharmaceutical Company Information
13.6.2 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.6.3 Hunan Er-Kang Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hunan Er-Kang Pharmaceutical Main Business Overview
13.6.5 Hunan Er-Kang Pharmaceutical Latest Developments
13.7 Changzhou Lanling Pharmaceutical
13.7.1 Changzhou Lanling Pharmaceutical Company Information
13.7.2 Changzhou Lanling Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.7.3 Changzhou Lanling Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Changzhou Lanling Pharmaceutical Main Business Overview
13.7.5 Changzhou Lanling Pharmaceutical Latest Developments
13.8 Baiao Pharmaceutical
13.8.1 Baiao Pharmaceutical Company Information
13.8.2 Baiao Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.8.3 Baiao Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Baiao Pharmaceutical Main Business Overview
13.8.5 Baiao Pharmaceutical Latest Developments
13.9 Guangdong Wonterfull ITD Pharmaceutical
13.9.1 Guangdong Wonterfull ITD Pharmaceutical Company Information
13.9.2 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.9.3 Guangdong Wonterfull ITD Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Guangdong Wonterfull ITD Pharmaceutical Main Business Overview
13.9.5 Guangdong Wonterfull ITD Pharmaceutical Latest Developments
13.10 Jiangsu Yuexing Pharmaceutical
13.10.1 Jiangsu Yuexing Pharmaceutical Company Information
13.10.2 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.10.3 Jiangsu Yuexing Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Jiangsu Yuexing Pharmaceutical Main Business Overview
13.10.5 Jiangsu Yuexing Pharmaceutical Latest Developments
13.11 Southwest Pharmaceutical
13.11.1 Southwest Pharmaceutical Company Information
13.11.2 Southwest Pharmaceutical Aminocaproic Acid Product Portfolios and Specifications
13.11.3 Southwest Pharmaceutical Aminocaproic Acid Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Southwest Pharmaceutical Main Business Overview
13.11.5 Southwest Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.